{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:39:16Z","timestamp":1790339956651,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR076900"],"award-info":[{"award-number":["R01AR076900"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS070328"],"award-info":[{"award-number":["R01NS070328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR078035"],"award-info":[{"award-number":["R01AR078035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR061484"],"award-info":[{"award-number":["R01AR061484"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR062207"],"award-info":[{"award-number":["R01AR062207"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.gendis.2025.101571","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:10:22Z","timestamp":1740222622000},"page":"101571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exogenous pyruvate is therapeutic against colitis by targeting cytosolic phospholipase A2"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-2705","authenticated-orcid":false,"given":"Sadaf","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8932-5586","authenticated-orcid":false,"given":"Xiangli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-ju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.gendis.2025.101571_bib1","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i41.15310","article-title":"Therapeutic effect of a hydroxynaphthoquinone fraction on dextran sulfate sodium-induced ulcerative colitis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gendis.2025.101571_bib2","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3389\/fimmu.2020.02058","article-title":"Astragalin attenuates dextran sulfate sodium (DSS)-induced acute experimental colitis by alleviating gut microbiota dysbiosis and inhibiting NF-\u03baB activation in mice","volume":"11","author":"Peng","year":"2020","journal-title":"Front Immunol"},{"issue":"22","key":"10.1016\/j.gendis.2025.101571_bib3","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.3390\/ijms20225751","article-title":"Chitosan ameliorates DSS-induced ulcerative colitis mice by enhancing intestinal barrier function and improving microflora","volume":"20","author":"Wang","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.gendis.2025.101571_bib4","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gendis.2025.101571_bib5","article-title":"Vitamin D treatment attenuates 2, 4, 6-trinitrobenzene sulphonic acid (TNBS)-induced colitis but not oxazolone-induced colitis","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.gendis.2025.101571_bib6","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3748\/wjg.v22.i11.3117","article-title":"Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer","volume":"22","author":"Landy","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"10080","key":"10.1016\/j.gendis.2025.101571_bib7","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.gendis.2025.101571_bib8","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3390\/ijms19082244","article-title":"Anti-TNF therapy in Crohn's disease","volume":"19","author":"Adegbola","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.gendis.2025.101571_bib9","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1038\/emm.2017.282","article-title":"Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"issue":"33","key":"10.1016\/j.gendis.2025.101571_bib10","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.3748\/wjg.v23.i33.6016","article-title":"Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis","volume":"23","author":"Eichele","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101571_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ibd.20753","article-title":"Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis","volume":"15","author":"Alex","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gendis.2025.101571_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.20.100301.064816","article-title":"The immunology of mucosal models of inflammation","volume":"20","author":"Strober","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib13","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1038\/s41598-021-84761-1","article-title":"DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice","volume":"11","author":"Kwon","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-007-2111-3","article-title":"Inflammatory bowel disease, past, present and future: lessons from animal models","volume":"43","author":"Mizoguchi","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.gendis.2025.101571_bib15","first-page":"15.25.1","article-title":"Dextran sulfate sodium (DSS)-induced colitis in mice","volume":"104","author":"Chassaing","year":"2014","journal-title":"Curr Protoc Im"},{"key":"10.1016\/j.gendis.2025.101571_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/718617","article-title":"Dextran sodium sulphate colitis mouse model: traps and tricks","volume":"2012","author":"Per\u0161e","year":"2012","journal-title":"J Biomed Biotechnol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101571_bib17","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat Protoc"},{"key":"10.1016\/j.gendis.2025.101571_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13020-020-0296-z","article-title":"Targeting NF-\u03baB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines","volume":"15","author":"Lu","year":"2020","journal-title":"Chin Med"},{"issue":"2","key":"10.1016\/j.gendis.2025.101571_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1615\/JEnvironPatholToxicolOncol.2014008425","article-title":"Protective effect of Acacia ferruginea against ulcerative colitis via modulating inflammatory mediators, cytokine profile and NF-\u03baB signal transduction pathways","volume":"33","author":"Sakthivel","year":"2014","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"10.1016\/j.gendis.2025.101571_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/949065","article-title":"Herb-partitioned moxibustion regulates the TLR2\/NF-\u03baB signaling pathway in a rat model of ulcerative colitis","volume":"2015","author":"Wang","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/15321819.2010.538108","article-title":"Expression of Toll-like receptor 4, CD14, and NF-\u03baB in Chinese patients with ulcerative colitis","volume":"32","author":"Yu","year":"2011","journal-title":"J Immunoassay Immunochem"},{"issue":"8","key":"10.1016\/j.gendis.2025.101571_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.arcmed.2008.08.001","article-title":"NF-\u03baB p65 antisense oligonucleotides may serve as a novel molecular approach for the treatment of patients with ulcerative colitis","volume":"39","author":"Li","year":"2008","journal-title":"Arch Med Res"},{"key":"10.1016\/j.gendis.2025.101571_bib23","article-title":"Analyzing beneficial effects of nutritional supplements on intestinal epithelial barrier functions during experimental colitis","volume":"119","author":"Vargas Robles","year":"2017","journal-title":"J Vis Exp"},{"issue":"22","key":"10.1016\/j.gendis.2025.101571_bib24","doi-asserted-by":"crossref","first-page":"31790","DOI":"10.18632\/oncotarget.9306","article-title":"Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.gendis.2025.101571_bib25","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/ard.2010.134684","article-title":"State-of-the-art: rheumatoid arthritis [published correction appears in Ann Rheum Dis. 2011;70(2):399]","volume":"69","author":"McInnes","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gendis.2025.101571_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep31159","article-title":"Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation","volume":"6","author":"McGuire","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.gendis.2025.101571_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gendis.2025.101571_bib28","article-title":"Intervention with \u03b1-ketoglutarate ameliorates colitis-related colorectal carcinoma via modulation of the gut microbiome","volume":"2019","author":"Li","year":"2019","journal-title":"BioMed Res Int"},{"issue":"7","key":"10.1016\/j.gendis.2025.101571_bib29","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gutjnl-2022-327337","article-title":"Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases","volume":"72","author":"Michaudel","year":"2023","journal-title":"Gut"},{"issue":"37","key":"10.1016\/j.gendis.2025.101571_bib30","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1021\/jf402515a","article-title":"Ingestion of low dose pyroglutamyl leucine improves dextran sulfate sodium-induced colitis and intestinal microbiota in mice","volume":"61","author":"Wada","year":"2013","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98082-w","article-title":"Role of pyruvate in maintaining cell viability and energy production under high-glucose conditions","volume":"11","author":"Yako","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1471-4159.2005.02999.x","article-title":"Protection by exogenous pyruvate through a mechanism related to monocarboxylate transporters against cell death induced by hydrogen peroxide in cultured rat cortical neurons","volume":"93","author":"Nakamichi","year":"2005","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.gendis.2025.101571_bib33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1124\/mol.106.024398","article-title":"A molecular mechanism of pyruvate protection against cytotoxicity of reactive oxygen species in osteoblasts","volume":"70","author":"Hinoi","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"9","key":"10.1016\/j.gendis.2025.101571_bib34","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s00125-003-1171-z","article-title":"Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes","volume":"46","author":"Chang","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.gendis.2025.101571_bib35","first-page":"1141","article-title":"Prevention of cataract in diabetic mice by topical pyruvate","volume":"5","author":"Hegde","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.gendis.2025.101571_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcp.2015.12.022","article-title":"Intestinal anti-inflammatory activity of calcium pyruvate in the TNBS model of rat colitis: comparison with ethyl pyruvate","volume":"103","author":"Algieri","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00217-015-2516-9","article-title":"The bioavailability of calcium in the form of pyruvate, carbonate, citrate\u2013malate in healthy postmenopausal women","volume":"242","author":"Rzymski","year":"2016","journal-title":"Eur Food Res Tech"},{"issue":"6","key":"10.1016\/j.gendis.2025.101571_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nm.4328","article-title":"Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction","volume":"23","author":"Qi","year":"2017","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.gendis.2025.101571_bib39","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1194\/jlr.R057588","article-title":"Cytosolic phospholipase A2: physiological function and role in disease","volume":"56","author":"Leslie","year":"2015","journal-title":"J Lipid Res"},{"issue":"20","key":"10.1016\/j.gendis.2025.101571_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011155","article-title":"Cytosolic phospholipase A2 is required for fexofenadine's therapeutic effects against inflammatory bowel disease in mice","volume":"22","author":"Zhao","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03227-20","article-title":"5-aminosalicylic acid ameliorates colitis and checks dysbiotic Escherichia coli expansion by activating PPAR-\u03b3 signaling in the intestinal epithelium","volume":"12","author":"Cevallos","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.gendis.2025.101571_bib42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-0716-1130-2_14","article-title":"Monitoring atsttrin-mediated inhibition of TNF\u03b1\/NF-\u03ba\u03b2 activation through in vivo bioluminescence imaging","volume":"2248","author":"Hettinghouse","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s42826-021-00084-2","article-title":"Inflammatory responses of C57BL\/6NKorl mice to dextran sulfate sodium-induced colitis: comparison between three C57BL\/6 N sub-strains","volume":"37","author":"Kim","year":"2021","journal-title":"Lab Anim Res"},{"issue":"4","key":"10.1016\/j.gendis.2025.101571_bib44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/gut.38.4.568","article-title":"Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat","volume":"38","author":"Butzner","year":"1996","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.gendis.2025.101571_bib45","first-page":"6069","article-title":"Amelioration of the DSS-induced colitis in mice by pretreatment with 4,4'-diaponeurosporene-producing Bacillus subtilis","volume":"14","author":"Jing","year":"2017","journal-title":"Exp Ther Med"},{"issue":"8","key":"10.1016\/j.gendis.2025.101571_bib46","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/ibd.21553","article-title":"Impact of disrupting adenosine A3 receptors (A3\u2013\/\u2013AR) on colonic motility or progression of colitis in the mouse","volume":"17","author":"Ren","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gendis.2025.101571_bib47","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.biopha.2017.10.010","article-title":"Protective effect of \u03b1-lipoic acid against spleen toxicity of dimethylnitrosamine in male mice: antioxidant and ultrastructure approaches","volume":"96","author":"El-Shenawy","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.gendis.2025.101571_bib48","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1038\/srep06420","article-title":"An efficient genotyping method for genome-modified animals and human cells generated with CRISPR\/Cas9 system","volume":"4","author":"Zhu","year":"2014","journal-title":"Sci Rep"},{"issue":"30","key":"10.1016\/j.gendis.2025.101571_bib49","doi-asserted-by":"crossref","first-page":"15588","DOI":"10.1074\/jbc.M116.734624","article-title":"Dual roles of group IID phospholipase A2 in inflammation and cancer","volume":"291","author":"Miki","year":"2016","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.gendis.2025.101571_bib50","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1158\/0008-5472.CAN-04-3446","article-title":"Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis","volume":"65","author":"Ilsley","year":"2005","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.gendis.2025.101571_bib51","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2019-215543","article-title":"Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis","volume":"78","author":"Liu","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gendis.2025.101571_bib52","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.gendis.2025.101571_bib54","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1462-5822.2010.01505.x","article-title":"Cytosolic phospholipase A2 as a mediator of disease pathogenesis","volume":"12","author":"Linkous","year":"2010","journal-title":"Cell Microbiol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gendis.2025.101571_bib56","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9318721","article-title":"The attenuation of chronic ulcerative colitis by (R)-salbutamol in repeated DSS-induced mice","volume":"2022","author":"Deng","year":"2022","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"10.1016\/j.gendis.2025.101571_bib57","first-page":"66","article-title":"Emerging biologic therapies in inflammatory bowel disease","volume":"4","author":"Lim","year":"2004","journal-title":"Rev Gastroenterol Disord"},{"issue":"4","key":"10.1016\/j.gendis.2025.101571_bib58","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.crohns.2011.10.004","article-title":"Anti-TNF-\u03b1 antibodies improve intestinal barrier function in Crohn's disease","volume":"6","author":"Noth","year":"2012","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.gendis.2025.101571_bib59","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000233283","article-title":"Therapeutic options to modulate barrier defects in inflammatory bowel disease","volume":"27","author":"Hering","year":"2009","journal-title":"Dig Dis"},{"issue":"6","key":"10.1016\/j.gendis.2025.101571_bib60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2796.2008.01953.x","article-title":"NF-kappaB in inflammatory bowel disease","volume":"263","author":"Atreya","year":"2008","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.gendis.2025.101571_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112583","article-title":"Pyruvate metabolism controls chromatin remodeling during CD4+ T cell activation","volume":"42","author":"Mocholi","year":"2023","journal-title":"Cell Rep"},{"issue":"18","key":"10.1016\/j.gendis.2025.101571_bib62","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.3390\/molecules25184112","article-title":"Ethyl pyruvate promotes proliferation of regulatory T cells by increasing glycolysis","volume":"25","author":"Koprivica","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.gendis.2025.101571_bib63","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MOG.0b013e32816aa392","article-title":"Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications","volume":"23","author":"Mankertz","year":"2007","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.gendis.2025.101571_bib64","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biopha.2018.01.168","article-title":"Regulation of JAK2\/STAT3 and NF-\u03baB signal transduction pathways; Veronica polita alleviates dextran sulfate sodium-induced murine colitis","volume":"100","author":"Akanda","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.gendis.2025.101571_bib65","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/gutjnl-2012-303252","article-title":"Collagen degradation and neutrophilic infiltration: a vicious circle in inflammatory bowel disease","volume":"63","author":"Koelink","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.gendis.2025.101571_bib66","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-0716-0954-5_15","article-title":"Drug affinity responsive target stability (DARTS) assay to detect interaction between a purified protein and a small molecule","volume":"2213","author":"Huang","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"51","key":"10.1016\/j.gendis.2025.101571_bib67","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2025.101571_bib68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1388-1981(00)00108-6","article-title":"Structure and mechanism of human cytosolic phospholipase A2","volume":"1488","author":"Dessen","year":"2000","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipds"},{"issue":"6","key":"10.1016\/j.gendis.2025.101571_bib69","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbalip.2018.08.006","article-title":"Cytosolic phospholipase A2 and lysophospholipid acyltransferases","volume":"1864","author":"Kita","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipds"},{"issue":"7","key":"10.1016\/j.gendis.2025.101571_bib70","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.3390\/molecules27072347","article-title":"Phosphorylation of cPLA2\u03b1 at Ser505 is necessary for its translocation to PtdInsP2-enriched membranes","volume":"27","author":"Casas","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.gendis.2025.101571_bib71","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1006\/bbrc.1996.1857","article-title":"Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid","volume":"229","author":"Camandola","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.gendis.2025.101571_bib72","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.20050665","article-title":"Cytosolic phospholipase A2\u03b1-deficient mice are resistant to experimental autoimmune encephalomyelitis","volume":"202","author":"Marusic","year":"2005","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.gendis.2025.101571_bib73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101571_bib74","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0896-6273(04)00003-0","article-title":"Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease","volume":"41","author":"Kalyvas","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.gendis.2025.101571_bib75","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/37635","article-title":"Reduced fertility and postischemic brain injury in mice deficient in cytosolic phospholipase A2","volume":"390","author":"Bonventre","year":"1997","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.gendis.2025.101571_bib76","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/jnci\/djq324","article-title":"Cytosolic phospholipase A2 and cancer: a role in tumor angiogenesis","volume":"102","author":"Tosato","year":"2010","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.gendis.2025.101571_bib77","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/brain\/aww295","article-title":"Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy","volume":"140","author":"Falik Zaccai","year":"2017","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.gendis.2025.101571_bib78","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13543776.2017.1246540","article-title":"Inhibitors of phospholipase A2 and their therapeutic potential: an update on patents (2012-2016)","volume":"27","author":"Kokotou","year":"2017","journal-title":"Expert Opin Ther Pat"},{"issue":"21","key":"10.1016\/j.gendis.2025.101571_bib79","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.2174\/0929867325666180117103919","article-title":"Targeting cytosolic phospholipase A2\u03b1 for novel anti-inflammatory agents","volume":"25","author":"Soubhye","year":"2018","journal-title":"Curr Med Chem"},{"issue":"5","key":"10.1016\/j.gendis.2025.101571_bib80","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0899-9007(99)00034-9","article-title":"The effects of pyruvate supplementation on body composition in overweight individuals","volume":"15","author":"Kalman","year":"1999","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.gendis.2025.101571_bib81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10408398.2011.565890","article-title":"Pyruvate supplementation for weight loss: a systematic review and meta-analysis of randomized clinical trials","volume":"54","author":"Onakpoya","year":"2014","journal-title":"Crit Rev Food Sci Nutr"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225000601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225000601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:19:13Z","timestamp":1751440753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2352304225000601"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101571","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exogenous pyruvate is therapeutic against colitis by targeting cytosolic phospholipase A2","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd\u00e9","name":"copyright","label":"Copyright"}],"article-number":"101571"}}